D. E. Shaw & Co., Inc. Bausch Health Companies Inc. Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 413,140 shares of BHC stock, worth $3.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

413,140

Previous 1,331,886 68.98%

Holding current value

$3.37 Million

Previous $14.1 Million 79.63%

% of portfolio

0.0%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$6.1 - $10.41 $5.6 Million - $9.56 Million	-918,746 Reduced 68.98%	413,140 $2.88 Million
Q1 2024 May 15, 2024	BUY	$7.77 - $10.61 $4.14 Million - $5.66 Million	533,194 Added 66.76%	1,331,886 $14.1 Million
Q4 2023 Feb 14, 2024	SELL	$6.53 - $8.23 $7.04 Million - $8.87 Million	-1,078,232 Reduced 57.45%	798,692 $6.41 Million
Q3 2023 Nov 14, 2023	SELL	$7.69 - $9.71 $10.7 Million - $13.5 Million	-1,394,683 Reduced 42.63%	1,876,924 $15.4 Million
Q2 2023 Aug 14, 2023	SELL	$5.72 - $8.8 $7.76 Million - $11.9 Million	-1,356,903 Reduced 29.32%	3,271,607 $26.2 Million
Q1 2023 May 15, 2023	SELL	$6.28 - $9.85 $9.93 Million - $15.6 Million	-1,581,395 Reduced 25.47%	4,628,510 $37.5 Million
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $12.3 Million - $16 Million	-2,018,023 Reduced 24.53%	6,209,905 $39 Million
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $12.1 Million - $24.3 Million	2,636,551 Added 47.15%	8,227,928 $56.7 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $32.6 Million - $109 Million	4,611,318 Added 470.51%	5,591,377 $46.7 Million
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $16.8 Million - $21.7 Million	779,205 Added 387.95%	980,059 $22.4 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $928,349 - $1.17 Million	40,363 Added 25.15%	200,854 $5.55 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $3.99 Million - $4.76 Million	145,458 Added 967.59%	160,491 $4.71 Million
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $1.73 Million - $2.78 Million	-80,825 Reduced 84.32%	15,033 $477,000
Q3 2020 Nov 16, 2020	BUY	$14.88 - $20.13 $382,832 - $517,904	25,728 Added 36.69%	95,858 $1.49 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $153,597 - $236,685	-11,540 Reduced 14.13%	70,130 $1.28 Million
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $364,585 - $448,049	-17,461 Reduced 17.61%	81,670 $1.78 Million
Q2 2019 Aug 14, 2019	SELL	$20.52 - $26.45 $4.75 Million - $6.12 Million	-231,502 Reduced 70.02%	99,131 $2.5 Million
Q1 2019 May 15, 2019	SELL	$20.23 - $26.29 $7.1 Million - $9.23 Million	-351,113 Reduced 51.5%	330,633 $8.17 Million
Q4 2018 Feb 14, 2019	SELL	$17.64 - $28.32 $12.1 Million - $19.4 Million	-686,554 Reduced 50.18%	681,746 $12.6 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $28.2 Million - $35.1 Million	1,368,300 New	1,368,300 $35.1 Million

Others Institutions Holding BHC

# of Institutions

275

Shares Held

279M

Call Options Held

5.68M

Put Options Held

17.4M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.95B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account